A carregar...
Guillain-Barré syndrome in a patient with multiple myeloma after bortezomib therapy: A case report
BACKGROUND: Bortezomib is a first-line drug approved for patients with multiple myeloma (MM) and has significantly increased their overall survival. However, bortezomib-induced peripheral neuropathy (PN) remains a significant side effect that has led to its discontinuation in some patients. Guillain...
Na minha lista:
| Publicado no: | World J Clin Cases |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Baishideng Publishing Group Inc
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6789385/ https://ncbi.nlm.nih.gov/pubmed/31616710 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12998/wjcc.v7.i18.2905 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|